Exogenous human surfactant for treatment of severe respiratory distress syndrome: A randomized prospective clinical trial*
References (20)
- et al.
Artificial surfactant therapy in hyaline membrane diseases
Lancet
(1980) - et al.
Dry artificial lung surfactant and its effect on very premature babies
Lancet
(1981) - et al.
Recurrence of symptomatic patent ductus arteriosus in extremely premature infants treated with indomethacin
J Pediatr
(1984) - et al.
Surfactant function in respiratory distress syndrome
J Pediatr
(1983) - et al.
Surface properties in relation to atelectasis and hyaline membrane disease
Am J Dis Child
(1959) - et al.
Isolation of human surfactant from amniotic fluid and a pilot study of its efficacy in respiratory distress syndrome
Pediatrics
(1981) - et al.
Immune complex formation in respiratory distress syndrome
Pediatr Res
(1984) - et al.
Hyaline membrane disease treated with bovine surfactant
Pediatrics
(1981) - et al.
Controlled trial of artificial surfactant to prevent respiratory distress syndrome
Lancet
(1977) - et al.
Absence of phosphatidylglycerol (PG) in respiratory distress syndrome in the newborn
Pediatr Res
(1977)
There are more references available in the full text version of this article.
Cited by (0)
- *
Supported by Grants HD-16292 (T.A.M.) and HD-10622 (L.G.) from the National Institute of Child Health and Human Development, by a Clinical Research Grant from the March of Dimes/Birth Defects Foundation (T.A.M.), by the Finnish Academy, and by the Sigrid Juselius Foundation (M.H.). Presented in part at a meeting of the Society for Pediatric Research, San Francisco, May 1984.
Copyright © 1985 Published by Mosby, Inc.